Worldwide, medical devices that cater for diabetics have improved considerably. However, insulin pens still require users to go through several steps and menus to record dosage data. Although there are dozens of glucose monitoring apps that can store dosage data, most do not provide integration with insulin pens which means dosage data must be entered manually.
New dosage data uploading platforms have the potential to facilitate better decision-making, tighten doctor patient feedback, and inform more holistic self-management of diabetes. One of these medtech developers is Dnurse, a Beijing based startup with white label medical devices that partners with diabetes management service providers, pharmaceuticals and insurers worldwide to help diabetics to manage their condition in a proactive manner. Some of these partnerships include;
Dnurse patented insulin. InsulinK is an insulin dosage monitor that utilizes audio processing, speech recognition, noise reduction and bluetooth to automatically record insulin dosages and recommend the appropriate dosage. identify anomalies in treatment and notify users in advance of complications.
2. India – Beato
Beato is an Indian based diabetes management platform that has chosen the Dnurse glucometer as the primary device for it’s users across 1500 Indian cities. As India is expected to have over 100 million diabetics by 2030, the opportunity for Beato to combine it’s analytics with the Dnurse Glucometer is significant. Furthermore, the fact that Dnurse’s Glucose meter can withstand 4000 uses makes it the most cost efficient option for diabetics in developing countries such as India.
3. UK / Kenya – Baobab Circle
Baobab circle is a UK based health/wellness platform with a focus on chronic diseases and is particularly active in the Kenya. Dnurse is partnering with Baobab as the Dnurse glucose meter retails for $7 dollars and this cost efficiency combined with the battery lifespan of five years makes it particularly suitable for developing markets.
3. Indonesia – Dexa Medica
Dexa Group is an Indonesian based pharmaceutical that manufacturers medication for Type 2 diabetes mellitus including branded generics and real generics. Dexa has also chosen the Dnurse Glucose Meter for it’s longevity, with 4000 uses and a 5 year lifespan.
4. MedWorks – Pakistan
Medworks is a Pakistan Diabetes. Control rate of Dnurse user’s blood glucose level often overlooked by pharmaceuticals and insurers and a metric often overlooked by pharmaceuticals and insurers and a crucial element of the diabetes management toolkit.
Ultimately, bridging the hardware gap can be a challenge for chronic disease management platforms and, as a result, most do not provide integration with insulin pumps which means dosage data must be tracked manually. By enhancing the offerings in a preventative rather than reactive manner Dnurse is offering pharmaceuticals, diabetes management platforms and insurers a white label hardware solution that many are striving for as consumers increasingly seek products that benefit them in a tangible way as opposed to remedying the consequences of misfortune.